During the past decade, Spaarne Gasthuis - locatie Zuid conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Spaarne Gasthuis - locatie Zuid" are "Atrial Fibrillation" (1 trials), "Atrial Fibrillation (AF)" (1 trials), "Heart Failure" (1 trials), "Prevention of Stroke or Systemic Embolism" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Spaarne Gasthuis - locatie Zuid" in a lesser frequency.

Most popular intervention types in "Spaarne Gasthuis - locatie Zuid" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "BAY2433334" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spaarne Gasthuis - locatie Zuid" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Spaarne Gasthuis - locatie Zuid". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Spaarne Gasthuis - locatie Zuid, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Spaarne Gasthuis - locatie Zuid, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".